Immunoadhesins of interleukin-6 and the IL-6/soluble IL-6R fusion protein hyper-IL-6

Journal of Immunological Methods

Volumn 223, Issue 2, 1999, Pages 171-183

  Jostock, Thomas ^a   Blinn, Guido ^a   Renné, Christoph ^a   Kallen, Karl Josef ^a   Rose John, Stefan ^a   Müllberg, Jürgen ^a  

^a Johannes G   (Germany)

Author keywords

Cytokines; Fc proteins; Immunoadhesins; Limited proteolysis; Mammalian expression; Receptors

Indexed keywords

ADHESIN; CYTOKINE; FC PROTEIN; GLYCOPROTEIN GP 130; HYBRID PROTEIN; IMMUNOADHESIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIMERIZATION; HEMATOPOIESIS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNE ADHERENCE; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; COS CELLS; DIMERIZATION; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; INTERLEUKIN-6; MICE; PROTEIN ENGINEERING; RECEPTORS, INTERLEUKIN-6; RECOMBINANT FUSION PROTEINS; THROMBIN; TUMOR CELLS, CULTURED;

EID: 0032986036     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00218-X     Document Type: Article

References (48)

1. Ashkenazi A., Chamow S.M. Immunoadhesins as research tools and therapeutic agents. Curr. Opin. Immunol. 9:1997;195.
2. Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Ruckert R., Krause H., Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3:1997;1124.
3. Castell J.V., Geiger T., Gross V., Andus T., Walter E., Hirano T., Kishimoto T., Heinrich P.C. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur. J. Biochem. 177:1988;357.
4. Chamow S.M., Ashkenazi A. Immunoadhesins: principles and application. Trends Biotechnol. 14:1996;52.
5. Chamow S.M., Peers D.H., Byrn R.A., Mulkerrin M.G., Harris R.J., Wang W.C., Bjorkman P.J., Capon D.J., Ashkenazi A. Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments. Biochemistry. 29:1990;9885.
6. Fanslow W.C., Anderson D.M., Grabstein K.H., Clark E.A., Cosman D., Armitage R.J. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149:1992;655.
7. Fischer M., Goldschmitt J., Peschel C., Kallen K.J., Brakenhoff J.P.J., Wollmer A., Grötzinger J., Rose-John S. A designer cytokine with high activity on human hematopoietic progenitor cells. Nature Biotechnol. 15:1997;142.
8. Gaillard J.-P., Liautard J., Klein B., Brochier J. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines. Eur. J. Immunol. 27:1997;3332.
9. Gearing D.P., Ziegler S.F., Comeau M.R., Friend D., Thoma B., Cosman D., Park L., Mosley B. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc. Natl. Acad. Sci. USA. 91:1994;1119.
10. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L.S., Cosman D., Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:1994;2822.
11. Heinrich, P.C., Rose-John, S., 1993. Interleukin-6. In: Sim, E. (Ed.), Humoral Factors. Oxford Univ. Press, Oxford, p. 47.
12. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S., Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 324:1986;73.
13. Horsten U., Schmitz Van de Leur H., Mullberg J., Heinrich P.C., Rose-John S. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett. 360:1995;43.
14. Jacob G.S., Kirmaier C., Abbas S.Z., Howard S.C., Steininger C.N., Welply J.K., Scudder P. Binding of sialyl Lewis x to E-selectin as measured by fluorescence polarization. Biochemistry. 34:1995;1210.
15. Kallen K.-J., Meyer zum Büschenfelde K.H., Rose-John S. The therapeutic potential of interleukin-6 hyperagonists and antagonists. Exp. Opin. Invest. Drugs. 6:1997;237.
16. Krauss S., Kufer P., Federle C., Tabaszewski P., Weiss E., Rieber E.P., Riethmuller G. Recombinant CD4-IgE, a novel hybrid molecule, inducing basophils to respond to human immunodeficiency virus (HIV) and HIV-infected target cells. Eur J. Immunol. 25:1995;192.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
18. Landolfi N.F. A chimeric IL-2/Ig molecule possesses the functional activity of both proteins. J. Immunol. 146:1991;915.
19. Lust J.A., Donovan K.A., Kline M.P., Greipp P.R., Kyle R.A., Maihle N.J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 4:1992;96.
20. Martin S., Casanovas J.M., Staunton D.E., Springer T.A. Successful prevention of rhinovirus infections with chimeric ICAM-1 immunoglobulin in vitro. Med. Klin. 88:1993;193.
21. März P., Herget T., Lang E., Otten U., Rose-John S. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur. J. Neurosci. 9:1997;2765.
22. März P., Cheng J.-C., Gadient R.A., Patterson P., Stoyan T., Otten U., Rose-John S. Sympathetic neurons can produce and respond to interleukin-6. Proc. Natl. Acad. Sci. USA. 95:1998;3251.
23. McMahan C.J., Slack J.L., Mosley B., Cosman D., Lupton S.D., Brunton L.L., Grubin C.E., Wignall J.M., Jenkins N.A., Brannan C.I., Copeland N.G., Huebner K., Croce C.M., Cannizzarro L.A., Benjamin D., Dower S.K., Spriggs M.K., Sims J.E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821.
24. Moreland L.W., Baumgartner S.W., Schiff M.H., Tindall E.A., Fleischmann R.M., Weaver A.L., Ettlinger R.E., Cohen S., Koopman W.J., Mohler K., Widmer M.B., Blosch C.M. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein, see comments. N. Engl. J. Med. 337:1997;141.
25. Müllberg J., Schooltink H., Stoyan T., Gunther M., Graeve L., Buse G., Mackiewicz A., Heinrich P.C., Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23:1993;473.
26. Oppmann B., Stoyan T., Fischer M., Voltz N., März P., Rose-John S. Alternative assay procedures for cytokines and soluble receptors of the IL-6 family. J. Immunol. Methods. 195:1996;153.
27. Özbek S., Grötzinger J., Krebs B., Fischer M., Wollmer A., Jostock T., Müllberg J., Rose-John S. The membrane proximal cytokine receptor domain of the human interleukin-6-receptor is sufficient for ligand binding but not for gp130 association. J. Biol. Chem. 273:1998;21374.
28. Peters M., Jacobs S., Ehlers M., Vollmer P., Müllberg J., Wolf E., Brem G., Meyer zum Büschenfelde K.H., Rose-John S. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1996;1399.
29. Peters M., Schirmacher P., Goldschmitt J., Odenthal M., Peschel C., Fattori E., Ciliberto G., Dienes H.P., Meyer zum Buschenfelde K.H., Rose-John S. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J. Exp. Med. 185:1997;755.
30. Renné C., Kallen K.J., Müllberg J., Jostock T., Grätzinger J., Rose-John S. A new type of cytokine receptor antagonist directly targeting gp130. J. Biol. Chem. 273:1998;27213.
31. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315.
32. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300:1994;281.
33. Rose-John S., Dietrich A., Marks F. Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblasts. Gene. 74:1988;465.
34. Rose-John S., Schooltink H., Schmitz-Van de Leur H., Müllberg J., Heinrich P.C., Graeve L. Intracellular retention of interleukin-6 abrogates signaling. J. Biol. Chem. 268:1993;22084.
35. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Schiel X., Rose-John S., Dufhues G., Schooltink H., Gross V., Heinrich P.C. Microheterogeneity of human interleukin-6 synthesized by transfected NIH/3T3 cells: comparison with human monocytes, fibroblasts and endothelial cells. Eur. J. Immunol. 20:1990;883.
37. Stoyan T., Michaelis U., Schooltink H., Van Dam M., Rudolph R., Heinrich P.C., Rose-John S. Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. Eur. J. Biochem. 216:1993;239.
38. Sui X., Tsuji K., Tanaka R., Tajima S., Muraoka K., Ebihara Y., Ikebuchi K., Yasukawa K., Taga T., Kishimoto T., Nakahata T. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA. 92:1995;2859.
39. Sui X., Tsuji K., Tajima S., Tanaka R., Muraoka K., Ebihara Y., Ikebuchi K., Yasukawa K., Taga T., Kishimoto T., Nakahata T. Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells. J. Exp. Med. 183:1996;837.
40. Taga T., Kishimoto T. gp130 and the Interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:1997;797.
41. Taga, T., Hibi, M., Hirata, Y., Yawata, H., Natsuka, S., Yasukawa, K., Totsuka, T., Yamasaki, K., Hirano, T., Kishimoto, T., 1989. Interleukin-6 receptor and a unique mechanism of its signal transduction. Cold Spring Harbor Symp. Quant. Biol., 54, Pt 2, 713.
42. Tajima S., Tsuji K., Ebihara Y., Sui X., Tanaka R., Muraoka K., Yoshida M., Yamada K., Yasukawa K., Taga T., Kishimoto T., Nakahata T. Analysis of interleukin-6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J. Exp. Med. 184:1996;1357.
43. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Yamada Y., Koishihara Y., Ohsugi Y., Kumaki K., Taga T., Kishimoto T., Suda T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. USA. 90:1993;11924.
44. Traunecker A., Schneider J., Kiefer H., Karjalainen K. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature. 339:1989;68.
45. Udagawa N., Takahashi N., Katagiri T., Tamura T., Wada S., Findlay D.M., Martin T.J., Hirota H., Taga T., Kishimoto T., Suda T. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182:1995;1461.
46. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 89:1992;4845.
47. Van Zee K.J., Moldawer L.L., Oldenburg H.S., Thompson W.A., Stackpole S.A., Montegut W.J., Rogy M.A., Meschter C., Gallati H., Schiller C.D., Richter W.F., Loetscher H., Ashkenazi A., Chamow S.M., Wurm F., Calvano S.E., Lowry S.F., Lesslauer W. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. J. Immunol. 156:1996;2221.
48. Zheng X.X., Steele A.W., Nickerson P.W., Steurer W., Steiger J., Strom T.B. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol. 154:1995;5590.